Login / Signup

Risk factors associated with biochemically detected and hospitalised acute kidney injury in patients prescribed renin angiotensin system inhibitors.

Patrick B MarkRichard PapworthNitish RamparsadLaurie A TomlinsonSimon SawhneyCorri BlackAlex McConnachieColin McCowan
Published in: British journal of clinical pharmacology (2020)
In patients prescribed ACEi/ARB, the highest risk of AKI is associated with conditions which are considered strong evidence-based indications for their prescription. Socio-economic status is an under-reported risk factor for AKI with these agents. Strategies targeted at prevention of AKI may be of benefit, such as enhanced awareness based on higher risk comorbidities.
Keyphrases
  • end stage renal disease
  • acute kidney injury
  • ejection fraction
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes
  • drug delivery